Search results for "Drug Interactions"
Hepatitis C drugs offer new options
The approval of multiple drugs in 2013 and 2014 that are able to cure hepatitis C without the use of interferon has dramatically changed the screening, treatment, and epidemiologic paradigms of the virus. Soon, internists will be involved in this rapidly changing area of health care.
https://immattersacp.org/archives/2015/01/hepatitis.htm
1 Jan 2015
Clarithromycin may cause serious adverse events when taken with certain statins
Clarithromycin may cause serious adverse events when taken with rosuvastatin, pravastatin, or fluvastatin, according to a new study.
https://immattersacp.org/weekly/archives/2015/01/13/6.htm
13 Jan 2015
Letters to the Editor
Readers respond to ACP Internist coverage of issues surround the time spent with patients, ICD-10 coding changes, and physician burnout.
https://immattersacp.org/archives/2015/03/letters.htm
1 Mar 2015
Mental health issues, addiction concerns of legal marijuana
Physicians in states that have legalized marijuana should begin to educate and prepare themselves for discussing the perils of recreational use and related illnesses, some of which can be severely debilitating.
https://immattersacp.org/archives/2015/05/marijuana.htm
1 May 2015
Warning on HCV treatments; more cancer drugs approved
This update also covers a warning that combination drugs can cause serious liver injury and approval of new drugs for metastatic non-small-cell lung cancer that has progressed after other treatments.
https://immattersacp.org/archives/2016/01/fda.htm
1 Jan 2016
Changes, challenges in treating heart failure
Readmissions among heart failure patients can be prevented with diligent, evidence-based primary care. But with their time at a premium, physicians can be increasingly concerned about meeting the needs of this population.
https://immattersacp.org/archives/2016/02/heart-failure.htm
1 Feb 2016
Managing depression is worth the effort
Depression's impact on health is often profound and far-reaching, potentially equaling that of coronary artery disease. To provide clinicians with guidance on treatment of depression, ACP has released a new clinical practice guideline that underscores the severe burden of depression and outlines viable treatment options for patients.
https://immattersacp.org/archives/2016/05/depression.htm
1 May 2016
MKSAP Quiz: severe, persistent, burning pain in an assisted-living patient
An 86-year-old woman is evaluated in her assisted-living facility for pain. Four weeks ago, she developed herpetic lesions on her right posterior thorax in a T7 distribution. She was treated with acyclovir, and the lesions healed; however, she has persistent severe burning pain. The pain is so severe that she is unable to leave her bed to attend meals. Following a physical exam, which medication is the most appropriate pharmacologic therapy for this patient's pain?
https://immattersacp.org/weekly/archives/2016/05/17/3.htm
17 May 2016
Guidance issued on drug-drug interactions for statins, heart meds
A new statement from the American Heart Association recommends that in patients taking amlodipine combined with simvastatin or lovastatin, the dosage of either statin should not exceed 20 mg/d, and for patients in whom statin-fibrate therapy is indicated, fenofibrate or fenofibric acid is preferred because of a lower rate of drug-drug interactions.
https://immattersacp.org/weekly/archives/2016/10/25/2.htm
25 Oct 2016
MKSAP Quiz: 1-week history of recurrent episodes of facial pain
A 36-year-old woman with relapsing-remitting MS is evaluated for a 1-week history of recurrent episodes of facial pain that are 1 to 3 seconds in duration and occur spontaneously dozens of times throughout the day. The pain is sharp, severe, and located in the right infraorbital area. During this same period, she has developed worsening bilateral lower extremity weakness and urinary incontinence. After a physical exam and lab studies, what is the most likely cause of the facial pain?
https://immattersacp.org/weekly/archives/2017/04/25/3.htm
25 Apr 2017